Lantian Tian

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

Yingjian Liang, Tongsen Zheng, Ruipeng Song et al. · Hepatology · 2013 · 292 citations

Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma

Ruiqi Liu, Yuejin Li, Lantian Tian et al. · Cancer Letters · 2018 · 140 citations

Tumor Biology, Health Sciences, Human Hepatocellular Carcinoma +13

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

Wenwen Zhang, Shuang Tong, Bingyang Hu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 109 citations · Full text

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

Wenwen Zhang, Bingyang Hu, Jun Han et al. · Frontiers in Oncology · 2021 · 70 citations · Full text

In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog

Haitao Liu, Yingjian Liang, Luoluo Wang et al. · PLoS ONE · 2012 · 59 citations · Full text

Chemoprevention Strategy, Pathology, Cell Death +18